Grows organoids from a patient's tumor and tests drugs on them in a CLIA-certified lab.
Consented intake · your records travel with you · nothing moves without your sign-off
SEngine offers CLIA-certified functional testing focused on solid tumors, using organoids grown from fresh tumor tissue. Drugs are applied to the tissue and the response is observed, with turnaround from two days to six weeks. For patients choosing between drugs, ex vivo results like these can add confidence that a treatment is likely to work for them.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how SEngine (organoids, CLIA-certified, focus on solid tumors) handles billing.
We don't have confirmed insurance details for SEngine (organoids, CLIA-certified, focus on solid tumors) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in SEngine's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.